Showing results (571-580 of 1,155) with videos related to
Sort By:
Pageof 116
European Radiology|April 29, 2015
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgeryH A Vargas, I A Burger, D A Goldman, et al.Gynecologic Oncology|September 18, 2010
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group StudyLeslie M Randall, Bradley J Monk, James Moon, et al.Journal of Materials Science. Materials in Medicine|August 10, 2006
Artificial midline-fascia of the human abdominal wall for testing suture strengthJ M van Os, J F Lange, R H M Goossens, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2016
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic ResponseIrene A Burger, Ruben Casanova, Seraina Steiger, et al.British Journal of Haematology|April 14, 2016
Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemiaShubhchintan Randhawa, Byung S Cho, Dipanjan Ghosh, et al.The New England Journal of Medicine|January 6, 2006
Intraperitoneal cisplatin and paclitaxel in ovarian cancerDeborah K Armstrong, Brian Bundy, Lari Wenzel, et al.Blood|July 2, 2009
Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutationsElias Jabbour, Daniel Jones, Hagop M Kantarjian, et al.Nuclear Medicine Communications|December 5, 2013
How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantificationIrene A Burger, Hebert A Vargas, Brad J Beattie, et al.AIDS (London, England)|June 4, 2016
Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodiesTom L G M van den Kerkhof, Marit J van Gils, Brigitte D Boeser-Nunnink, et al.The Journal of Physical Chemistry. A|November 30, 2017
Effective Polarizability ModelsJohannes Fiedler, Priyadarshini Thiyam, Anurag Kurumbail, et al.Pageof 116